Cerus (CERS) Restructuring Costs (2010)

Cerus (CERS) reported Restructuring Costs of -$182000.0 for Q4 2010, up 9.45% sequentially from -$201000.0 in Q3 2010.

Cerus (CERS) Restructuring Costs (2010) Analysis & Trends

Cerus (CERS) has 1 years of Restructuring Costs data on file, last reported at -$182000.0 in Q4 2010.

For the quarter ending Q4 2010, Restructuring Costs changed N/A year-over-year to -$182000.0; the trailing twelve-month figure through Dec 2011 stood at -$182000.0 (changed N/A YoY), and the FY2009 full-year result was $841000.0, changed N/A from the prior year.
Restructuring Costs grew to -$182000.0 in Q4 2010, from -$201000.0 in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $132000.0 in Q2 2010 to a low of -$201000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.94 Bn	176.64 Bn	6.27 Bn
2	Stryker	128.78 Bn	125.90 Bn	3.81 Bn
3	Medtronic	109.01 Bn	99.79 Bn	6.41 Bn
4	Boston Scientific	68.59 Bn	67.13 Bn	3.61 Bn
5	Edwards Lifesciences	47.66 Bn	43.99 Bn	1.29 Bn
6	GE HealthCare Technologies	28.36 Bn	26.07 Bn	1.98 Bn
7	Dexcom	28.30 Bn	27.18 Bn	750.30 Mn
8	Smith & Nephew	26.93 Bn	26.36 Bn	-
9	Koninklijke Philips	25.45 Bn	22.33 Bn	2.07 Bn
10	Cerus	598.93 Mn	518.50 Mn	27.89 Mn

Download Data